查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1462972

流感診斷市場,佔有率,市場規模,趨勢,行業分析報告:依產品,測試類型,最終用途,地區,細分市場預測2024-2032 年

Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的一項新研究，到 2032 年，全球流感診斷市場預計將達到 14.6 億美元。該研究報告提供了對當前市場動態的詳細洞察，並對未來市場成長進行了分析。

由於全世界對流感的認識和關注不斷增加，流感診斷市場正在成長。流感具有高度傳染性，可導致嚴重疾病，因此早期發現和管理變得越來越重要。每年發生的流行病凸顯了準確診斷的必要性，以減少對個人和醫療保健系統的影響。此外，流感大流行的經濟和社會影響增加了對有效診斷解決方案的需求。COVID-19 大流行進一步凸顯了呼吸道感染的風險，並刺激了對診斷測試的需求。快速現場檢測和分子檢測等先進技術可提供更快、更準確的結果，從而促進市場成長。

老年人和慢性病患者特別容易出現流感併發症，需要及時、準確的診斷。隨著世界人口結構轉向人口老化和慢性病的增加，對流感診斷解決方案的需求不斷增加。老年人的免疫系統通常較弱，這使他們患流感的風險增加。同樣，患有慢性病的人也更容易受到傷害。醫療保健提供者正在優先考慮對這一群體進行早期流感檢測，以預防併發症。此外，由於人口老化和慢性病，流感對醫療保健系統帶來的負擔不斷增加，增加了對有效診斷工具的需求。

遠端監控和遠距醫療解決方案使醫療保健提供者能夠遠端診斷流感，從而最大限度地減少醫院就診的需要。患者可以在家中諮詢醫療保健專業人員，減少接觸傳染病的機會。遠距醫療平台整合了遠端體溫監測設備和數位溫度計等診斷工具，用於即時症狀評估。穿戴式科技持續監測生命徵象，可以幫助診斷流感。此外，這些解決方案還優化了資源分配並降低了醫療成本。透過促進及時診斷和治療來增強患者治療效果和疾病管理。

由於多重檢測的日益普及，流感診斷市場的需求也激增。多重檢測可以在一次測試中同時檢測多種病原體，包括流感病毒和其他呼吸道病原體。多重檢測可提供更快的周轉時間、減少樣本量並提高診斷準確性。多重檢測簡化了工作流程，改善了病患管理策略，並透過最大限度地減少多次檢測的需要來節省資源。隨著醫療保健系統專注於增強呼吸道感染的診斷能力，對多重檢測的需求預計將繼續增加並推動市場成長。

流感診斷市場報告亮點

2023年，由於醫療環境中的廣泛採用、流感季節的高需求、政府措施和疫情對策，檢測試劑盒和試劑產業佔銷售額的很大一部分。

2023年，RIDT領域由於見效快、成本效益高且用途廣泛，佔據了很大的銷售佔有率。

到 2023 年，由於病患量大、醫療保健服務全面，並且可以獲得專業設備，醫院部門將佔據重要的銷售佔有率。

2023年，北美地區憑藉先進的醫療基礎設施、高額醫療支出以及主要市場參與者的強大影響力，在全球市場中佔據主導地位。

該市場由 Abbott Laboratories、Becton、Dickinson and Company (BD)、bioMerieux SA、F. Hoffmann-La Roche Ltd.、Luminex Corporation、Meridian Bioscience, Inc.、Quidel Corporation 和 Thermo Fisher Scientific Inc. 等全球公司主導由於有實力雄厚的公司進入市場，競爭非常激烈。

目錄

第一章簡介

第二章執行摘要

第三章研究方法論

第四章全球流感診斷市場洞察

  • 流感診斷市場－最終用途概況
  • 流感診斷市場動態
    • 驅動因素和機遇
      • 流感發生率上升預計將增加產品需求
      • 越來越多地採用現場檢測預計將推動流感診斷市場的成長。
    • 限制因素和課題
      • 監管課題和合規要求可能會阻礙市場成長
  • PESTEL 分析
  • 流感診斷市場最終用途趨勢
  • 價值鏈分析
  • COVID-19 影響分析

第五章依測試類型劃分的全球市場

  • 主要發現
  • 介紹
  • RIDT
  • 細胞培養
  • 逆轉錄聚合酶鏈反應
  • 其他

第六章依產品劃分的世界市場

  • 主要發現
  • 介紹
  • 機器
  • 檢測試劑盒和試劑
  • 其他

第七章依最終用途劃分的全球市場

  • 主要發現
  • 介紹
  • 醫院
  • 診斷實驗室
  • 其他

第八章依地區劃分的世界市場

  • 主要發現
  • 介紹
    • 2019-2032 年流感診斷市場評估（依地區）
  • 流感診斷市場 - 北美
    • 北美：流感診斷市場，依測試類型，2019-2032
    • 北美：流感診斷市場，依最終用途，2019-2032 年
    • 北美：流感診斷市場（依產品），2019-2032 年
    • 流感診斷市場—美國
    • 流感診斷市場－加拿大
  • 流感診斷市場—歐洲
    • 歐洲：流感診斷市場，依檢驗類型，2019-2032
    • 歐洲：流感診斷市場，依最終用途，2019-2032 年
    • 歐洲：流感診斷市場（依產品），2019-2032
    • 流感診斷市場—英國
    • 流感診斷市場—法國
    • 流感診斷市場—德國
    • 流感診斷市場—義大利
    • 流感診斷市場—西班牙
    • 流感診斷市場—荷蘭
    • 流感診斷市場—俄羅斯
  • 流感診斷市場－亞太地區
    • 亞太地區：流感診斷市場（依檢驗類型），2019-2032 年
    • 亞太地區：流感診斷市場（依最終用途），2019-2032 年
    • 亞太地區：流感診斷市場（依產品），2019-2032 年
    • 流感診斷市場—中國
    • 流感診斷市場—印度
    • 流感診斷市場 - 馬來西亞
    • 流感診斷市場—日本
    • 流感診斷市場—印度尼西亞
    • 流感診斷市場—韓國
  • 流感診斷市場—中東和非洲
    • 中東和非洲：流感診斷市場（依測試類型），2019-2032 年
    • 中東和非洲：流感診斷市場（以最終用途），2019-2032 年
    • 中東和非洲：流感診斷市場（依產品），2019-2032 年
    • 流感診斷市場－沙烏地阿拉伯
    • 流感診斷市場－阿聯酋
    • 流感診斷市場—以色列
    • 流感診斷市場—南非
  • 流感診斷市場 - 拉丁美洲
    • 拉丁美洲：流感診斷市場（依測試類型），2019-2032 年
    • 拉丁美洲：流感診斷市場，依最終用途，2019-2032 年
    • 拉丁美洲：流感診斷市場（依產品），2019-2032 年
    • 流感診斷市場—墨西哥
    • 流感診斷市場—巴西
    • 流感診斷市場—阿根廷

第9章 競爭格局

  • 擴張和收購分析
    • 擴張
    • 收購
  • 夥伴關係/協作/協議/出版物

第十章公司簡介

  • Abbott Laboratories
  • Becton, Dickinson and Company（BD）
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • CorisBioConcept
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • GenMark Diagnostics, Inc.
  • Hologic, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc.
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Sekisui Diagnostics
  • Thermo Fisher Scientific Inc.
Product Code: PM4663

The global influenza diagnostics market size is expected to reach USD 1.46 billion by 2032, according to a new study by Polaris Market Research. The report "Influenza Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Test Kit and Reagents, Others); By Test Type; By End Use; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The influenza diagnostics market is growing due to heightened awareness and concerns about influenza globally. With influenza's contagious nature and potential for severe illness, there's increasing emphasis on early detection and management. Annual outbreaks underscore the necessity for accurate diagnosis to mitigate its impact on individuals and healthcare systems. Additionally, the economic and societal repercussions of influenza outbreaks drive demand for effective diagnostic solutions. The COVID-19 pandemic has further highlighted respiratory infection risks, fueling demand for diagnostic testing. Advanced technologies like rapid point-of-care tests and molecular assays offer faster, more accurate results, contributing to market growth.

Elderly individuals and those with chronic diseases are especially susceptible to severe influenza complications, necessitating timely and accurate diagnostics. With global demographics shifting towards aging populations and rising chronic conditions, demand for influenza diagnostic solutions is heightened. Elderly individuals often have compromised immune systems, elevating their influenza risk. Similarly, those with chronic ailments face increased vulnerability. Healthcare providers prioritize early influenza detection in these groups to prevent complications. Additionally, the burden of influenza on healthcare systems intensifies with aging populations and chronic conditions, driving the need for effective diagnostic tools.

Remote monitoring and telemedicine solutions enable healthcare providers to diagnose influenza remotely, minimizing the need for in-person visits. Patients can consult healthcare professionals from home, reducing exposure to infectious diseases. Telemedicine platforms integrate diagnostic tools like remote temperature monitoring devices and digital thermometers for real-time symptom assessment. Wearable technology continuously monitors vital signs, aiding influenza diagnosis. Additionally, these solutions optimize resource allocation and reduce healthcare costs. By facilitating timely diagnosis and treatment, they enhance patient outcomes and disease management.

The influenza diagnostics market is also witnessing a surge in demand driven by the growing adoption of multiplex assays. These assays enable simultaneous detection of various pathogens, including influenza viruses and other respiratory pathogens, in a single test. They offer faster turnaround times, reduced sample volumes, and enhanced diagnostic accuracy. Multiplex assays streamline workflows, improve patient management strategies, and conserve resources by minimizing the need for multiple tests. As healthcare systems focus on enhancing their capacity for diagnosing respiratory infections, the demand for multiplex assays is expected to continue rising, fueling market growth.

Influenza Diagnostics Market Report Highlights

In 2023, the test kit and reagents segment held a significant revenue share owing to wide adoption in healthcare settings, high demand during flu seasons, and government initiatives and pandemic preparedness.

In 2023, the RIDT segment held a significant revenue share owing to rapid results, cost-effectiveness, and established usage.

In 2023, the hospital's segment held a significant revenue share owing to high patient footfall, comprehensive healthcare services, and access to specialized equipment.

In 2023, the North America region dominated the global market due to advanced healthcare infrastructure, high healthcare spending, and the strong presence of key market players.

The market is highly competitive owing to the existence of market players with a global presence, including Abbott Laboratories, Becton, Dickinson and Company (BD), bioMerieux SA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, and Thermo Fisher Scientific Inc. among others.

Polaris Market Research has segmented the Influenza Diagnostics market report based on product, test type, end use, and region:

Influenza Diagnostics, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Instruments
  • Test Kit and Reagents
  • Others

Influenza Diagnostics, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • RIDT
  • Cell Culture
  • RT-PCR
  • Others

Influenza Diagnostics, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals
  • Diagnostic Laboratories
  • Others

Influenza Diagnostics, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Netherlands
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Indonesia
  • South Korea
  • Australia
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Diagnostics Market Insights

  • 4.1. Influenza Diagnostics Market - End Use Snapshot
  • 4.2. Influenza Diagnostics Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing incidence of influenza is projected to spur product demand
      • 4.2.1.2. Increasing adoption of point-of-care testing is expected to drive influenza diagnostics market growth
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory challenges and compliance requirements are likely to impede the market growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Diagnostics Market End Use Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Diagnostics Market, by Test Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • 5.3. RIDT
    • 5.3.1. Global Influenza Diagnostics Market, by RIDT, by Region, 2019-2032 (USD Billion)
  • 5.4. Cell Culture
    • 5.4.1. Global Influenza Diagnostics Market, by Cell Culture, by Region, 2019-2032 (USD Billion)
  • 5.5. RT-PCR
    • 5.5.1. Global Influenza Diagnostics Market, by RT-PCR, by Region, 2019-2032 (USD Billion)
  • 5.6. Others
    • 5.6.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Influenza Diagnostics Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 6.3. Instruments
    • 6.3.1. Global Influenza Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Billion)
  • 6.4. Test Kit and Reagents
    • 6.4.1. Global Influenza Diagnostics Market, by Test Kit and Reagents, by Region, 2019-2032 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Influenza Diagnostics Market, by Others, by Region, 2019-2032 (USD Billion)

7. Global Influenza Diagnostics Market, by End Use

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • 7.3. Hospitals
    • 7.3.1. Global Influenza Diagnostics Market, by Hospitals, By Region, 2019-2032 (USD Billion)
  • 7.4. Diagnostic Laboratories
    • 7.4.1. Global Influenza Diagnostics Market, by Diagnostic Laboratories, By Region, 2019-2032 (USD Billion)
  • 7.5. Others
    • 7.5.1. Global Influenza Diagnostics Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Influenza Diagnostics Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Influenza Diagnostics Market - North America
    • 8.3.1. North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.3.2. North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.3.3. North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.4. Influenza Diagnostics Market - U.S.
      • 8.3.4.1. U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.3.5. Influenza Diagnostics Market - Canada
      • 8.3.5.1. Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.4. Influenza Diagnostics Market - Europe
    • 8.4.1. Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.4. Influenza Diagnostics Market - UK
      • 8.4.4.1. UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.5. Influenza Diagnostics Market - France
      • 8.4.5.1. France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.6. Influenza Diagnostics Market - Germany
      • 8.4.6.1. Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.7. Influenza Diagnostics Market - Italy
      • 8.4.7.1. Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.8. Influenza Diagnostics Market - Spain
      • 8.4.8.1. Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.9. Influenza Diagnostics Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.4.10. Influenza Diagnostics Market - Russia
      • 8.4.10.1. Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.5. Influenza Diagnostics Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.4. Influenza Diagnostics Market - China
      • 8.5.4.1. China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.5. Influenza Diagnostics Market - India
      • 8.5.5.1. India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.6. Influenza Diagnostics Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.7. Influenza Diagnostics Market - Japan
      • 8.5.7.1. Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.8. Influenza Diagnostics Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.5.9. Influenza Diagnostics Market - South Korea
      • 8.5.9.1. South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.6. Influenza Diagnostics Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.4. Influenza Diagnostics Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.5. Influenza Diagnostics Market - UAE
      • 8.6.5.1. UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.6. Influenza Diagnostics Market - Israel
      • 8.6.6.1. Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.6.7. Influenza Diagnostics Market - South Africa
      • 8.6.7.1. South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • 8.7. Influenza Diagnostics Market - Latin America
    • 8.7.1. Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.4. Influenza Diagnostics Market - Mexico
      • 8.7.4.1. Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.5. Influenza Diagnostics Market - Brazil
      • 8.7.5.1. Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
    • 8.7.6. Influenza Diagnostics Market - Argentina
      • 8.7.6.1. Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Becton, Dickinson and Company (BD)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. bioMerieux SA
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. CorisBioConcept
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. DiaSorin S.p.A.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. GenMark Diagnostics, Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Hologic, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Luminex Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Meridian Bioscience, Inc.
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Quidel Corporation
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. SA Scientific, Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Sekisui Diagnostics
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Thermo Fisher Scientific Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 2 Global Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 3 Global Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 4 Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 6 North America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 7 North America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 8 U.S.: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 9 U.S.: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 10 U.S.: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 11 Canada: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 12 Canada: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 13 Canada: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 14 Europe: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 15 Europe: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 16 Europe: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 17 UK: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 18 UK: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 19 UK: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 20 France: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 21 France: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 22 France: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 23 Germany: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 24 Germany: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 25 Germany: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 26 Italy: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 27 Italy: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 28 Italy: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 29 Spain: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 30 Spain: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 31 Spain: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 35 Russia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 36 Russia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 37 Russia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 41 China: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 42 China: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 43 China: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 44 India: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 45 India: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 46 India: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 50 Japan: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 51 Japan: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 52 Japan: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 56 South Korea: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 57 South Korea: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 58 South Korea: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 65 UAE: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 66 UAE: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 67 UAE: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 68 Israel: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 69 Israel: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 70 Israel: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 71 South Africa: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 72 South Africa: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 73 South Africa: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 74 Latin America: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 75 Latin America: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 76 Latin America: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 77 Mexico: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 78 Mexico: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 79 Mexico: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 80 Brazil: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 81 Brazil: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 82 Brazil: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)
  • Table 83 Argentina: Influenza Diagnostics Market, by Test Type, 2019-2032 (USD Billion)
  • Table 84 Argentina: Influenza Diagnostics Market, by Product, 2019-2032 (USD Billion)
  • Table 85 Argentina: Influenza Diagnostics Market, by End Use, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Influenza Diagnostics Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Influenza Diagnostics Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Test Type
  • Figure 9. Global Influenza Diagnostics Market, by Test Type, 2022 & 2032 (USD Billion)
  • Figure 10. Market by End Use
  • Figure 11. Global Influenza Diagnostics Market, by End Use, 2022 & 2032 (USD Billion)
  • Figure 12. Influenza Diagnostics Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Influenza Diagnostics Market